CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Proteo Inc  (PTEO)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Proteo Inc's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

PTEO Gross Margin (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Revenue Change 8.67 % - -30.33 % -66.27 % -79.71 %
Y / Y Gross Profit Change - - - - -
Gross Margin - - - - -
Gross Margin Total Ranking # 588 # 573 # 0 # #
Seq. Revenue Change -26.43 % -52.79 % 145.97 % 27.21 % -
Seq. Gross Profit Change - - - - -


Commenting First Quarter 2017 Gross Margin
Proteo Inc experienced contraction in Gross Profit by -26.43 % to $0 millions and Revenue by -26.43 %, while Gross Margin fell to 100 % a new company low.

Observing first quarter 2017 results within Biotechnology & Drugs industry 49 other companies have achieved higher Gross Margin. While overall Gross Margin ranking remained unchanged compare to previous quarter at no. .
Learn about Gross Margin
PTEO's Gross Margin first quarter 2017 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 50
Healthcare Sector # 154
Overall # 588

Gross Margin Statistics
High Average Low
100 % 100 % 100 %
(Mar 31 2017)  

You need to upgrade your Flash Player


Financial Statements
Proteo Inc's (Mar 31 2017) Gross Profit $ 0 PTEO's Income Statement
Proteo Inc's (Mar 31 2016) Gross Profit $ 0 Quarterly PTEO's Growth
PTEO's Profits by Division See PTEO's Profits by Segment

Other Gross Margin Profitability Ratios
PTEO's Cumulative Gross Margin
Biotechnology & Drugs Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
PTEO's Gross Margin Profitability versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for PTEO's Competitors
Gross Margin Profit Margin for Proteo Inc's Suppliers
Gross Margin Profit Margin for PTEO's Customers

You may also want to know
PTEO's Annual Growth Rates PTEO's Profitability Ratios PTEO's Asset Turnover Ratio PTEO's Dividend Growth
PTEO's Roe PTEO's Valuation Ratios PTEO's Financial Strength Ratios PTEO's Gross Profit Growth
PTEO's Roa PTEO's Inventory Turnover Ratio PTEO's Growth Rates PTEO's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Mar 31 2017, within Biotechnology & Drugs Industry Gross MarginMar 31 2017 MRQ Gross ProfitMar 31 2017 MRQ Revenue
Sangui Biotech International Inc  217.68 %$ 0.025 $ 0.012 
Cytomx Therapeutics, Inc.  100.00 %$ 11.653 $ 11.653 
Crispr Therapeutics Ag  100.00 %$ 2.703 $ 2.703 
Champions Oncology, Inc.  100.00 %$ 3.719 $ 3.719 
Neuralstem, Inc.  100.00 %$ 0.003 $ 0.003 
Oncobiologics, Inc.  100.00 %$ 0.303 $ 0.303 
Opiant Pharmaceuticals, Inc.  100.00 %$ 0.018 $ 0.018 
Curis Inc  100.00 %$ 2.131 $ 2.131 
Cocrystal Pharma, Inc.  100.00 %$ 0.002 $ 0.002 
Cerecor Inc.  100.00 %$ 0.384 $ 0.384 
Proteo Inc  100.00 %$ 0.038 $ 0.038 
Coherus Biosciences, Inc.  100.00 %$ 0.161 $ 0.161 
Pulse Biosciences, Inc.  100.00 %$ 0.039 $ 0.039 
Cannabics Pharmaceuticals Inc.  100.00 %$ 0.001 $ 0.001 
Dimension Therapeutics, Inc.  100.00 %$ 3.618 $ 3.618 
Spark Therapeutics, Inc.  100.00 %$ 1.274 $ 1.274 
Momenta Pharmaceuticals Inc  100.00 %$ 26.614 $ 26.614 
Mymetics Corp  100.00 %$ 0.383 $ 0.383 
Kite Pharma, Inc.  100.00 %$ 9.836 $ 9.836 
Idera Pharmaceuticals, Inc.  100.00 %$ 0.378 $ 0.378 
Innovus Pharmaceuticals, Inc.  100.00 %$ 2.177 $ 2.177 
Juno Therapeutics, Inc.  100.00 %$ 19.327 $ 19.327 
Myokardia Inc  100.00 %$ 5.625 $ 5.625 
Northsight Capital, Inc.  100.00 %$ 0.003 $ 0.003 
Enumeral Biomedical Holdings, Inc.  100.00 %$ 0.029 $ 0.029 
Novavax Inc  100.00 %$ 5.680 $ 5.680 
Enzon Pharmaceuticals, Inc.  100.00 %$ 1.440 $ 1.440 
Fate Therapeutics Inc  100.00 %$ 1.027 $ 1.027 
Nantkwest, Inc.  100.00 %$ 0.011 $ 0.011 
Intellia Therapeutics, Inc.  100.00 %$ 6.215 $ 6.215 
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NCAP's Profile

Stock Price

NCAP's Financials

NCAP's Expectations

Business Description

Fundamentals

Charts & Quotes

NCAP's News

Suppliers

NCAP's Competitors

Customers & Markets

Economic Indicators

NCAP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com